BiotechTube
Home/bioAffinity Technologies/Julie Anne Overton
JA

Julie Anne Overton

Director of Communications

bioAffinity Technologies

Therapeutic Areas

OncologyPulmonology

bioAffinity Technologies Pipeline

DrugIndicationPhase
CyPath® LungEarly-stage lung cancer diagnosisCommercial
Platform Expansion - DiagnosticsOther cancers (unspecified)Research & Development
Therapeutic DiscoveryTargeted cancer treatmentResearch & Development

Leadership Team at bioAffinity Technologies

MZ
Maria Zannes
President and Chief Executive Officer
WB
W.E. Bauta
Scientist/Researcher (co-author)
MG
M.H. Grayson
Scientist/Researcher (co-author)
RT
R. Titone
Scientist/Researcher (co-author)
JR
J. Rebeles
Scientist/Researcher (co-author)
VR
V.I. Rebel
Scientist/Researcher (co-author)
ML
M.E. Lemieux
Scientist/Researcher (co-author)
XR
X.T. Reveles
Scientist/Researcher (co-author)
LB
L.H. Bederka
Scientist/Researcher (co-author)
PA
P.R. Araujo
Scientist/Researcher (co-author)
View full bioAffinity Technologies profile